Literature DB >> 36196143

Combination of TyG Index and GRACE Risk Score as Long-Term Prognostic Marker in Patients with ACS Complicated with T2DM Undergoing PCI.

Zhen Qin1,2,3, Shuai Xu1,2,3, Ruixia Yuan4, Zeyu Wang1,2,3, Yongzheng Lu1,2,3, Yanyan Xu1,2,3, Yan Lv1,2,3, Fengyi Yu1,2,3, Jing Bai1,2,3, Hui Zhang1,2,3, Li Zhang1,2,3, Jinying Zhang1,2,3, Junnan Tang1,2,3.   

Abstract

Objective: We aimed to investigate the prognostic value of the triglyceride-glucose (TyG) index combined the with Global Registry of Acute Coronary Events (GRACE) score in adult acute coronary syndrome (ACS) patients with type 2 diabetes mellitus (T2DM) who underwent percutaneous coronary intervention (PCI).
Methods: The study enrolled total 899 ACS patients with T2DM who underwent PCI. TyG index and the GRACE risk score were calculated and assessed by median. The correlation was analyzed by Spearman's rank correlation coefficient. The cumulative major adverse cardiovascular event (MACE) curve was generated using the Kaplan-Meier method. Multivariate Cox regression was used to identify predictors of MACEs. Additionally, the receiver operating characteristic curve (ROC), net reclassification index (NRI) and Integrated Discrimination Improvement (IDI) were applied to analyze the performance of each single factor index and combined multivariate index in predicting MACE.
Results: In the ACS patients with T2DM after PCI, there were significant differences in the TyG index and GRACE risk score between the MACE group and the MACE-free group (P < 0.001). Kaplan-Meier analysis showed that the TyG index combined with the GRACE risk score was positively correlated with the occurrence of MACEs (log rank P < 0.001). Multivariate Cox regression analyses showed that the TyG index, the GRACE risk score, and the TyG index combined with the GRACE risk score were independent predictors of long-term MACEs (adjusted HR: 1.805; 95% CI: 1.479-2.203, P < 0.001; adjusted HR: 1.012; 95% CI: 1.009-1.016, P < 0.001; and adjusted HR: 2.337; 95% CI: 1.805-3.025, P < 0.001, respectively). Correlation analysis indicated that the TyG index was positively correlated with the GRACE risk score (R = 0.140, P < 0.001). The analysis of AUC, NRI and IDI revealed that the combined multivariate index performed better prognostic role than each single factor index in predicting the occurrence of MACE.
Conclusion: Both the GRACE risk score and the TyG index could be significant and independent predictors of clinical outcomes in ACS patients with T2DM after PCI. A combination of them could be enhanced predictions of clinical outcomes in these patients.
© 2022 Qin et al.

Entities:  

Keywords:  GRACE risk score; acute coronary syndrome; percutaneous coronary intervention; predictive biomarker; triglyceride-glucose index; type 2 diabetes mellitus

Year:  2022        PMID: 36196143      PMCID: PMC9527003          DOI: 10.2147/DMSO.S376178

Source DB:  PubMed          Journal:  Diabetes Metab Syndr Obes        ISSN: 1178-7007            Impact factor:   3.249


  29 in total

Review 1.  Coronary Artery Disease and Type 2 Diabetes Mellitus.

Authors:  Ryo Naito; Katsumi Miyauchi
Journal:  Int Heart J       Date:  2017-07-14       Impact factor: 1.862

Review 2.  2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.

Authors:  Glenn N Levine; Eric R Bates; John A Bittl; Ralph G Brindis; Stephan D Fihn; Lee A Fleisher; Christopher B Granger; Richard A Lange; Michael J Mack; Laura Mauri; Roxana Mehran; Debabrata Mukherjee; L Kristin Newby; Patrick T O'Gara; Marc S Sabatine; Peter K Smith; Sidney C Smith
Journal:  Circulation       Date:  2016-03-29       Impact factor: 29.690

Review 3.  Diagnosis and management of acute coronary syndrome: an evidence-based update.

Authors:  Jennifer N Smith; Jenna M Negrelli; Megha B Manek; Emily M Hawes; Anthony J Viera
Journal:  J Am Board Fam Med       Date:  2015 Mar-Apr       Impact factor: 2.657

Review 4.  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018.

Authors: 
Journal:  Diabetes Care       Date:  2018-01       Impact factor: 19.112

5.  IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.

Authors:  N H Cho; J E Shaw; S Karuranga; Y Huang; J D da Rocha Fernandes; A W Ohlrogge; B Malanda
Journal:  Diabetes Res Clin Pract       Date:  2018-02-26       Impact factor: 5.602

6.  Optimization of GRACE Risk Stratification by N-Terminal Pro-B-type Natriuretic Peptide Combined With D-Dimer in Patients With Non-ST-Elevation Myocardial Infarction.

Authors:  Peng-Ju Lu; Xiao-Wen Gong; Yin Liu; Feng-Shi Tian; Wen-Juan Zhang; Ying-Wu Liu; Zhu-Hua Yao; Ji-Xiang Wang; Peng Han; Ya-Nan Yang; Zhuang Cui; Jing Gao
Journal:  Am J Cardiol       Date:  2020-11-04       Impact factor: 2.778

7.  Clinical impact of estimated plasma volume status and its additive effect with the GRACE risk score on in-hospital and long-term mortality for acute myocardial infarction.

Authors:  Tsutomu Kawai; Daisaku Nakatani; Takahisa Yamada; Yasuhiko Sakata; Shungo Hikoso; Hiroya Mizuno; Shinichiro Suna; Tetsuhisa Kitamura; Katsuki Okada; Tomoharu Dohi; Takayuki Kojima; Bolrathanak Oeun; Akihiro Sunaga; Hirota Kida; Hiroshi Sato; Masatsugu Hori; Issei Komuro; Shunsuke Tamaki; Takashi Morita; Masatake Fukunami; Yasushi Sakata
Journal:  Int J Cardiol Heart Vasc       Date:  2021-03-11

8.  Influence of the Triglyceride-Glucose Index on Adverse Cardiovascular and Cerebrovascular Events in Prediabetic Patients With Acute Coronary Syndrome.

Authors:  Qianyun Guo; Xunxun Feng; Bin Zhang; Guangyao Zhai; Jiaqi Yang; Yang Liu; Yuyang Liu; Dongmei Shi; Yujie Zhou
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-22       Impact factor: 5.555

9.  Value of neutrophil-to-lymphocyte ratio and its combination with GRACE risk score in predicting PCI outcomes in acute coronary syndrome.

Authors:  Can Ramazan Öncel
Journal:  Anatol J Cardiol       Date:  2016-06       Impact factor: 1.596

10.  Triglyceride-Glucose Index as a Surrogate Marker of Insulin Resistance for Predicting Cardiovascular Outcomes in Nondiabetic Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.

Authors:  Qi Zhao; Ting-Yu Zhang; Yu-Jing Cheng; Yue Ma; Ying-Kai Xu; Jia-Qi Yang; Yu-Jie Zhou
Journal:  J Atheroscler Thromb       Date:  2020-11-13       Impact factor: 4.928

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.